t
| Date | 17 Apr 2023 |
| Time | 07:00:05 |
| Category | Miscellaneous |
| ID | 3428W |
17 April 2023
LEI: 213800RG7JNX7K8F7525
LIFE SCIENCE REIT PLC
(the "Company", "Life Science REIT" or, together with its subsidiaries, the "Group")
Notice of Capital Markets Day
Life Science REIT (LSE: LABS), the real estate investment trust focused on UK life science properties, is pleased to announce that tomorrow, Tuesday 18 April 2023, it will host a capital markets day for institutional investors and research analysts at London's Francis Crick Institute, one of the foremost biomedical research centres in the UK.
The event will include presentations by Ironstone Asset Management, Life Science REIT's investment adviser, and by specialists in life science company formation and development and industry workplace design. Presenters will include Chris Hollowood, the Chief Executive Officer of Syncona Investment Management, and Jim Wilkinson, the Chief Financial Officer of Oxford Science Enterprises. The event will include a panel discussion and a Q&A session.
The event, on the morning of 18 April 2023, will be webcast live from 10.00am via the following link:
https://stream.buchanan.uk.com/broadcast/642423ae03867fad45f7be52
Shareholders are invited to send any questions by email in advance of the capital markets day to [email protected].
Following the event, a recording of the webcast will be made available on the Company's website, https://lifesciencereit.co.uk.
For further information, please contact Buchanan at [email protected].
No new price-sensitive information is expected to be announced on the day.
Enquiries:
|
Link Company Matters Limited - Company Secretary |
|
|
|
|
|
|
|
|
Ironstone Asset Management - Investment Adviser |
|
|
Simon Farnsworth, Managing Director |
|
|
Joanna Waddingham, Head of Investor Relations and Corporate Affairs |
|
|
|
|
|
|
|
|
Panmure Gordon (UK) Limited - Joint Corporate Broker |
+44 20 7886 2500 |
|
Alex Collins / Tom Scrivens |
|
|
|
|
|
Jefferies International Limited - Joint Corporate Broker |
+44 20 7029 8000 |
|
Tom Yeadon / Andrew Morris / Oliver Nott / Harry Randall
|
|
|
G10 Capital Limited - AIFM |
+44 20 7397 5450 |
|
Verity Morgan-Jones / Paul Cowland |
|
|
|
|
|
Buchanan - Financial PR |
+44 20 7466 5000 |
|
Mark Court / Henry Wilson / Verity Parker |
|
|
|
Notes to editors
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the "Golden Triangle" of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter and its strategic vision is to become the property provider of choice for life science companies in the UK.
Life Science REIT is addressing the acute demand-supply imbalance for laboratory space in the "Golden Triangle", which is characterised by low vacancy rates and prime rental increases. The UK life science sector itself is benefiting from a buoyant early-stage funding environment, driving demand for laboratory space.
The Company's diverse portfolio of assets ranges from a 20-acre science park currently under development through to fully let buildings, with an important part of the Company's strategy being the conversion of existing properties to laboratory space.
The Company's investment policy is focused on capital growth whilst also providing a growing level of income.
Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.
Further information is available at https://lifesciencereit.co.uk. To sign up for email alerts, please visit https://lifesciencereit.co.uk/investors/.